| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9754 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.8280 |
| P-glycoprotein Substrate | Substrate | 0.6367 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.6429 |
| Non-inhibitor | 0.9333 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.7453 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7437 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8222 |
| CYP450 2D6 Substrate | Non-substrate | 0.8968 |
| CYP450 3A4 Substrate | Substrate | 0.7867 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8944 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8654 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8922 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7617 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8467 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8156 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8594 |
| Non-inhibitor | 0.6749 |
| AMES Toxicity | Non AMES toxic | 0.8890 |
| Carcinogens | Non-carcinogens | 0.9243 |
| Fish Toxicity | High FHMT | 0.9955 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9889 |
| Honey Bee Toxicity | High HBT | 0.8112 |
| Biodegradation | Not ready biodegradable | 0.9890 |
| Acute Oral Toxicity | IV | 0.4939 |
| Carcinogenicity (Three-class) | Non-required | 0.4654 |